Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ CancersKathryn G. Roberts, Nicole M. Verrills|Cancer Research|2010Cited by 130
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J. Duchatel, David M. Ashley, Dilana E. Staudt et al.|Journal of Clinical Investigation|2024Cited by 44
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J. Duchatel, Matthew D. Dun, Evangeline R. Jackson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1